Kyung‐Lyum Min

McGill University

Papers

1

Total Citations

128

H-Index

1

About

Kyung-Lyum Min is a biochemist and molecular biologist whose research focuses on antiviral drug discovery, particularly targeting human immunodeficiency virus (HIV). His major contributions center on the development of innovative high-throughput screening assays to identify inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H (RNase H) activity. His most-cited work, a 2003 paper describing a fluorescence-based high-throughput screening assay for RNase H inhibitors, has garnered 128 citations, reflecting its foundational role in enabling the search for novel anti-HIV therapeutics. This assay provided a rapid, sensitive method to detect compounds that disrupt viral replication, addressing a critical need in combating drug-resistant HIV strains. Min’s work has been instrumental in bridging biochemical assay design with practical drug discovery, offering a platform for identifying lead compounds that could be developed into treatments. His achievements underscore a commitment to translating fundamental virology into actionable screening tools, making him a notable figure in the fight against HIV/AIDS.

Research Focus

Key Achievements

1
H-Index
1
Papers
128
Total Citations
128
Avg Citations/Paper
🏆 Most Cited Paper
A fluorescence-based high-throughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity
128 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: McGill University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago